Oncology

Pass out this resource to clients with affected dogs.

Dr. Timothy Fan answers this reader query about controlling cancer pain.

Can you discover the cause?

Tips for catching this invasive neoplasia as early as possible.

Follow this step-by-step guide to prepare a high-quality slide, increasing the value of its interpretation.

College Station, Texas - A study shows that a new immunotherapy for dogs diagnosed with advanced-stage non-Hodgkins lymphoma (NHL) could improve their survival time and quality of life.

A recent study investigated this option for treating this common urinary tract malignancy.

Make rounds with these veterinary specialists and residents for a complete picture of this neoplasia in dogs.

Advanced medicine gives pets a chance in the fight against pet cancer, but it's important to protect yourself and your employees when dealing with these dangerous drugs.

The vaccine shows an increase in survival time for dogs with spontaneous non-Hodgkin's lymphoma.

Cells from normal tissues live harmoniously, maintaining an appropriate distance from each other without piling up. They divide only at the rate necessary for replacement of tissue which has died from aging or injury.

Soft tissue sarcomas of the cat come in several forms. Injection site sarcomas/Vaccine associated sarcomas are the most common sarcomas seen in feline patients today.

Mast cell tumors (MCT) are the most common skin tumors in the dog. They represent 16-21% of all skin tumors. There are two forms in the dog, the dermal form and visceral form in the dog.

Lymphoma is considered to be the most common cancer in the cat. Lymphoma can affect cats of any age group and any breed. There seems to be biphasic occurrence with a peak in young cats and then another peak in middle aged to slightly older cats.

Bladder tumors represent < 2% of all canine malignancies. Transitional cell carcinoma is the most common histologic type diagnosed in both cats and dogs.

Osteosarcoma (OSA) is the most common primary bone tumor in dogs accounting for up to 85% of bone tumors in the dog.

A certain scent is associated with lung cancer, and dogs can detect it.

Carvallis, Ore. - Canine cancer is presenting new opportunities for veteirnary and medical researchers to develop new treatment strategies.

Davis, Calif. - A protein recently identified by veterinary researchers at the University of California-Davis may be key to diagnosing and treating lymphoma in animals and humans.

Detecting this mainly localized disease process early is difficult but important to improve an animal's prognosis.

Soft tissue sarcomas comprise 7% and 15% of all skin and subcutaneous tumors in cats and dogs, respectively. The annual incidence of soft tissue sarcomas in companion animals is approximately 17 per 100,000 cats and 35 per 100,000 dogs.

Mast cell tumors (MCT) are the most frequently encountered dermal/subcutaneous neoplasm in dogs representing 7% to 21% of all skin tumors in this species. Most MCT develop in older dogs and no sex predilection has been reported.

Most primary tumors are best treated by surgical excision. Most benign tumors, low grade cutaneous mast cell tumors, odontogenic tumors, or solitary mammary tumors are perhaps best treated by wide surgical excision.

Nasal and paranasal sinus tumors represent only 1-2% of all tumors but 60-80% of all canine respiratory tract tumors, and are even less frequent in cats. Nasal tumors occur most commonly in the nasal cavity with secondary extension into the frontal and other paranasal sinuses.

The process of radiation oncology from the time of patient identification to completion of radiation therapy is undoubtedly a complex one and requires significant communication between all services from the moment a potential radiation patient is seen and certainly prior to any surgical intervention. Listed below is an outline of the radiation process and treatment considerations at each step.